Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse-Reference-Cited by-同舟云学术

Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse

Published:2017-12-12 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Roviezzo Fiorentina,Rossi Antonietta,Caiazzo Elisabetta,Orlando Pierangelo,Riemma Maria A.,Iacono Valentina M.,Guarino Andrea,Ialenti Armando,Cicala Carla,Peritore Alessio,Capasso Raffaele,Di Marzo Vincenzo,Izzo Angelo A.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference52 articles.

1. Harnessing the anti-inflammatory potential of palmitoylethanolamide.;Alhouayek;Drug Discov. Today,2014

2. A proposed autacoid mechanism controlling mastocyte behaviour.;Aloe;Agents Actions,1993

3. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.;Bandiera;Pharmacol. Res.,2014

4. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.;Borrelli;Br. J. Pharmacol.,2015

5. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.;Boyce;Immunol. Rev.,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceutical formulation based on a synergic combination of melatonin and palmitoylethanolamide for the management of allergic events;Frontiers in Nutrition;2024-08-27

2. Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain;Pharmacology & Therapeutics;2024-06

3. CSF N-acylethanolamine acid amidase level and Parkinson's disease risk: A mendelian randomization study;Parkinsonism & Related Disorders;2024-06

4. Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator;Future Pharmacology;2023-12-15

5. The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis—A Double-Blind Placebo-Controlled Trial;Nutrients;2023-11-28